NCT07020702Recruiting
ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction
Source: ClinicalTrials.gov · Last updated 10 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
EP-SCOPE is a prospective, multicentric, non-randomized pilot study that aims to estimate the risk of life-threatening ventricular arrhythmia through use of advanced electrophysiological studies in patients with ischemic or non-ischemic cardiomyopathy with left ventricular ejection fraction (LVEF) \<50% and risk factors of ventricular arrhythmia, otherwise not considered for implantation of an implantable cardioverter defibrillator (ICD). The objective is to assess the effectiveness of a risk stratification strategy based on detailed electrophysiological exploration of the left ventricle and programmed ventricular stimulation.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 210 (estimated)
- First submitted
- 5 Jun 2025
- Start date
- 12 Jun 2023
- Primary completion date
- 12 Sept 2030
- Lead sponsor
- University Hospital, Bordeaux
- Diseases
- Coronary artery disease
- NCT number
- NCT07020702
What you commit to
- Study type: Interventional
- Planned participants: 210
- From 12 Jun 2023 to the primary completion date, 12 Sept 2030
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Anti-arrhythmic drugs other than beta-blockers and amiodarone
Other illness
- Patients with unstable coronary artery disease
- Myocardial infarction less than 40 days old
- Patients with a mechanical heart valve
Age
- Patients who are minors or aged 80 or over
Other
- Coronary revascularisation \<90 days
- Patients with intracardiac thrombus
- Patient implanted with an automatic defibrillator
- Patient life expectancy \<1 year
- Pregnant or breast-feeding women
Who the study is looking for
- Patient with cardiomyopathy with 35%\<LVEF\<50% and at least one risk factor
- Patients with cardiomyopathy with LVEF≤35% and an indication for cardiac resynchronisation
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Clermont-Ferrand Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Recruiting |
| CHU de Bordeaux - Hôpital Cardiologique du Haut-Lévèque Coordinator of this site? Confirm its status | Pessac | France | Recruiting |
| Chu de Saint Etienne Coordinator of this site? Confirm its status | Saint-Etienne | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.